Ionis Pharmaceuticals reported $6.34B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Astellas Pharma JPY 3.94T 622.52B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Celltrion KRW 1.81T 620B Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Exelixis USD 14.47B 933M Sep/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
OPKO Health USD 2.73B 1.76B Mar/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Sartorius EUR 17.42B 1.8B Sep/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 65.93B 25.23B Jun/2026